Workflow
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Reuters·2025-11-20 20:36

Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business. ...